Biotransformation of oleaside A (1) by Cunninghamella echinulata (ACCC 30369) was carried out to afford two products, (6R)-6-hydroxyoleaside A (2) and (7S)-7-hydroxyoleaside A (3). The structures of 2 and 3 were elucidated by extensive NMR analyses and further confirmed by single-crystal X-ray diffraction analysis. We also report herein the X-ray diffraction structure of oleaside A (1) for the first time. Compounds 1 -3 were evaluated for their cytotoxic activities against the A549, HCT116, HepG2, and HL-60 human cancer cell lines.Introduction. -Microbial transformation is an effective tool for the structural modification of natural bioactive compounds. Its application in asymmetric synthesis is increasing due to its versatility and simplicity [1]. A variety of transformations on natural products such as oxidation, reduction, hydrolysis, isomerization, epimerization, rearrangement, d-homoannulation, Michael addition, and reverse aldol reaction have already been performed [2]. Cunninghamella echinulata, a filamentous fungus, is recognized for its potential for steroid hydroxylation and has been noted for its ability to mimic mammalian hepatic metabolism with other substrates [3] [4].Oleaside A (1) is one of the most important cardiac glycosides derived from the Nerium oleander L. Recently, the anticancer effects of cardiac glycosides have been reported [5 -7]. In continuation of our biotransformation studies on the natural anticancer products [8] [9], we now report the characterization of two metabolites of oleaside A (1) in cell suspension of C. echinulata (ACCC 30369). These metabolites were identified as (6R)-6-hydroxyoleaside A (2) and (7S)-7-hydroxyoleaside A (3) by spectroscopic methods. We also report here the X-ray diffraction structure of these three compounds. Compounds 1 -3 (see Fig. 1) were evaluated for their cytotoxic activities against the A549, HCT116, HepG2, and HL-60 human cancer cell lines.